Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DCR-MYC |
Synonyms | |
Therapy Description |
DCR-MYC is a small-interfering RNA (siRNA) against c-Myc, which inhibits c-Myc translation and leads to growth inhibition of tumor cells (PMID: 31866228). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DCR-MYC | DCR-M1711|MYC-targeting siRNA DCR-MYC | c-MYC Inhibitor 12 | DCR-MYC is a small-interfering RNA (siRNA) against c-Myc, which inhibits c-Myc translation and leads to growth inhibition of tumor cells (PMID: 31866228). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02314052 | Phase Ib/II | DCR-MYC | Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma | Terminated | USA | 2 |
NCT02110563 | Phase I | DCR-MYC | Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma | Terminated | USA | 0 |